Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 27 | 26 | 26 | 25 | 25 |
| Accounts receivable | -114 | -30 | 84 | 67 | 15 |
| Other Working Capital | 119 | -631 | -622 | 671 | -152 |
| Other Operating Activity | -7,550 | -4,590 | -6,412 | -5,314 | -7,042 |
| Operating Cash Flow | $-7,518 | $-5,225 | $-6,925 | $-4,551 | $-7,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -3 | -3 | -6 | -12 |
| Investing Cash Flow | $-48 | $-3 | $-3 | $-6 | $-12 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14 | -14 | -14 | -14 | -14 |
| Common Stock Issued | 14,850 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,236 | 15,561 | 0 | 34 | 0 |
| Financing Cash Flow | $13,600 | $15,547 | $-14 | $20 | $-14 |
| Exchange Rate Effect | 222 | -524 | 369 | -561 | -108 |
| Beginning Cash Position | 21,417 | 11,622 | 18,195 | 23,293 | 30,580 |
| End Cash Position | 27,673 | 21,417 | 11,622 | 18,195 | 23,293 |
| Net Cash Flow | $6,035 | $10,319 | $-6,942 | $-4,537 | $-7,180 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,518 | -5,225 | -6,925 | -4,551 | -7,154 |
| Capital Expenditure | -48 | -3 | -3 | -6 | -12 |
| Free Cash Flow | -7,565 | -5,228 | -6,928 | -4,557 | -7,166 |